BACKGROUND: No studies have investigated the relation between K-ras mutations and dietary factors in exocrine pancreatic cancer (EPC), and fewer than 10 studies have done so in other neoplasms. PATIENTS AND METHODS: Incident cases of EPC were prospectively identified, and interviewed face-to-face during hospital admission. Food and nutrient intakes were measured with a food frequency questionnaire. Logistic regression was used to compare EPC cases (n = 107) with and without K-ras mutations (case-case study). RESULTS: K-ras mutations were more common among daily consumers of milk and other dairy products than among non-daily consumers: the odds ratio adjusted by total energy, age, sex, smoking, alcohol and coffee consumption (ORa) was 5.1 (95% CI 1.1 to 24.5, p = 0.040). For all dairy products, including butter, the ORa for the medium and upper tertiles of intake were 5.4 and 11.6, respectively (p for trend = 0.023). The ORa for regular coffee drinkers further adjusted by dairy consumption was 4.7 (95% CI 1.1 to 20.7, p = 0.043). K-ras mutated cases reported a lower intake of vitamin E (ORa = 0.2, p for trend = 0.036), polyunsaturated fats and omega 3 fatty acids (ORa = 0.2; p for trend <0.03). CONCLUSIONS: Results support the hypothesis that in EPC exposure to specific dietary components or contaminants may influence the occurrence or persistence of K-ras mutations.
BACKGROUND: No studies have investigated the relation between K-ras mutations and dietary factors in exocrine pancreatic cancer (EPC), and fewer than 10 studies have done so in other neoplasms. PATIENTS AND METHODS: Incident cases of EPC were prospectively identified, and interviewed face-to-face during hospital admission. Food and nutrient intakes were measured with a food frequency questionnaire. Logistic regression was used to compare EPC cases (n = 107) with and without K-ras mutations (case-case study). RESULTS:K-ras mutations were more common among daily consumers of milk and other dairy products than among non-daily consumers: the odds ratio adjusted by total energy, age, sex, smoking, alcohol and coffee consumption (ORa) was 5.1 (95% CI 1.1 to 24.5, p = 0.040). For all dairy products, including butter, the ORa for the medium and upper tertiles of intake were 5.4 and 11.6, respectively (p for trend = 0.023). The ORa for regular coffee drinkers further adjusted by dairy consumption was 4.7 (95% CI 1.1 to 20.7, p = 0.043). K-ras mutated cases reported a lower intake of vitamin E (ORa = 0.2, p for trend = 0.036), polyunsaturated fats and omega 3 fatty acids (ORa = 0.2; p for trend <0.03). CONCLUSIONS: Results support the hypothesis that in EPC exposure to specific dietary components or contaminants may influence the occurrence or persistence of K-ras mutations.
Authors: Rachael Z Stolzenberg-Solomon; Pirjo Pietinen; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes Journal: Am J Epidemiol Date: 2002-05-01 Impact factor: 4.897
Authors: E Kampman; D W Voskuil; A A van Kraats; H F Balder; G N van Muijen; R A Goldbohm; P van't Veer Journal: Carcinogenesis Date: 2000-02 Impact factor: 4.944
Authors: M Porta; N Malats; L Guarner; A Carrato; J Rifà; A Salas; J M Corominas; M Andreu; F X Real Journal: J Epidemiol Community Health Date: 1999-11 Impact factor: 3.710
Authors: G R Howe; P Ghadirian; H B Bueno de Mesquita; W A Zatonski; P A Baghurst; A B Miller; A Simard; J Baillargeon; F de Waard; K Przewozniak Journal: Int J Cancer Date: 1992-05-28 Impact factor: 7.396
Authors: M E Martínez; T Maltzman; J R Marshall; J Einspahr; M E Reid; R Sampliner; D J Ahnen; S R Hamilton; D S Alberts Journal: Cancer Res Date: 1999-10-15 Impact factor: 12.701
Authors: J A Hoppin; P E Tolbert; E A Holly; J W Brock; S A Korrick; L M Altshul; R H Zhang; P M Bracci; V W Burse; L L Needham Journal: Cancer Epidemiol Biomarkers Prev Date: 2000-02 Impact factor: 4.254
Authors: Rick J Jansen; Dennis P Robinson; Rachael Z Stolzenberg-Solomon; William R Bamlet; Mariza de Andrade; Ann L Oberg; Kari G Rabe; Kristin E Anderson; Janet E Olson; Rashmi Sinha; Gloria M Petersen Journal: J Gastrointest Cancer Date: 2013-06